1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

Cell lines tested with tanespimycin:bortezomib (250:1 mol/mol)

797 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
IGROV-1 ovary CTRPv22
Download CSV
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MRPL1 CTRPv2 AAC 0.17 4e-06
mRNA TM9SF4 CTRPv2 AAC -0.17 5e-06
mRNA NBR1 CTRPv2 AAC -0.18 5e-06
mRNA NEDD9 CTRPv2 AAC -0.17 6e-06
mRNA DNAJB2 CTRPv2 AAC -0.18 6e-06
mRNA ADAT2 CTRPv2 AAC 0.2 6e-06
mRNA PPA2 CTRPv2 AAC 0.17 6e-06
mRNA TYW3 CTRPv2 AAC 0.17 6e-06
mRNA YIPF2 CTRPv2 AAC -0.17 7e-06
mRNA MEMO1 CTRPv2 AAC 0.17 7e-06
Download CSV